MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2+-dependent toxicity linked to release
E.C. Azmitia, R.B. Murphy, P.M. Whitaker-Azmitia
Brain Research February 1, 1990 DOI: 10.1016/0006-8993(90)90732-q via OpenAlex
Summary
AI-generated from the abstractThe S(+) enantiomer of MDMA is ten times more potent than the R(-) enantiomer at inhibiting the development of serotonin uptake capacity in fetal rat raphe neurons. Both calcium-dependent and calcium-independent release of serotonin contribute to MDMA's toxic effect on these neurons, with the direct, transporter-mediated release being the first step. The serotonin 5-HT2 receptor, linked to increased intracellular calcium, is involved, as the antagonist ketanserin attenuates the effect of S(+)-MDMA. These findings clarify the cellular mechanisms of MDMA's serotonergic neurotoxicity.
Study at a glance
| Characteristics | In vitro experimental study Peer reviewed |
|---|---|
| Population | Fetal rat raphe neurons in culture |
| Interventions | S(+)-MDMA R(-)-MDMA fluoxetine alpha-2 agonists ketanserin |
| Dose | 5 × 10⁻⁶ M S(+)-MDMA, 5 × 10⁻⁵ M R(-)-MDMA |
| Duration | 4-day cultures |
| Topics | MDMA Serotonin |
| Keywords | Pharmacology Toxicity |
| Citations | 68 |
| Key finding | The S(+) enantiomer of MDMA is ten times more potent than the R(-) enantiomer at inhibiting serotonin uptake capacity in cultured raphe neurons, and both calcium-dependent and calcium-independent release mechanisms, along with 5-HT2 receptor activation, contribute to this toxicity. |
Abstract
Animal studies have established a correlation between release of 5-hydroxytryptamine (5-HT) and the long-term reduction of 5-HT (toxicity) by 3,4-methylenedioxymethamphetamine (MDMA) with the S(+) enantiomer being more active than the R(-). Using a microculture system of fetal raphe neurons, the enantiomers of MDMA were tested to determine if a similar difference in potency existed. The results showed that the development of the uptake capacity of [3H]5-HT in 4-day cultures was half-maximally inhibited by a single application at time of plating of 5 X 10(-6) M S(+)-MDMA and 5 X 10(-5) M R(-)-MDMA. In order to determine if the Ca2(+)-independent release (chemically induced through the transporter protein and inhibited by reuptake blockers) or the Ca2(+)-dependent release (K(+)-induced and inhibited by presynaptic receptors) contributed to the toxicity, fluoxetine and D1 and alpha 2 agonists were studied. The results showed that both forms of release were involved in the loss of [3H]5-HT uptake capacity, with the direct MDMA-induced Ca2(+)-independent (fluoxetine-sensitive) release being the first step. Evidence from binding studies indicates that MDMA has a micromolar affinity for the 5-HT2 receptor, and our studies in culture showed that ketanserin, a specific 5-HT2 antagonist, was effective at attenuating the effects of S(+)-MDMA on the development of the [3H]5-HT uptake capacity by the cultured raphe neurons. The 5-HT2 receptor is linked to increased intracellular Ca2+ through a second messenger phosphatidylinositol (PI)-hydrolysis mechanism.(ABSTRACT TRUNCATED AT 250 WORDS)